Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-06-06
1997-12-02
Bernhardt, Emily
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544233, 544234, 548492, A61K 3150, C07D48704
Patent
active
056936400
ABSTRACT:
the 2-position by an optionally substituted phenyl moiety, are selective non-competitive antagonists of NMDA receptors and/or are antagonists of AMPA receptors, and are therefore of utility in the treatment and/or prevention of conditions, such as neurodegenerative disorders, convulsions or schizophrenia, which require the administration of an NMDA and/or AMPA antagonist.
REFERENCES:
patent: 5599814 (1997-02-01), Bare et al.
Choi, Neuron 1, pp. 623-634 (1988).
Koh et al, Brain Research, 533, pp. 315-320 (1990).
Trujillo et al, Science 251, pp. 85-87 (1991).
Ladduwahetty Tamara
MacLeod Angus Murray
Bernhardt Emily
Merck Sharp & Dohme Ltd.
North Robert J.
Winokur Melvin
LandOfFree
Pyridazino-indole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridazino-indole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridazino-indole derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-801453